EXTENSIVE STAGE LUNG SMALL CELL CANCER
Clinical trials for EXTENSIVE STAGE LUNG SMALL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE LUNG SMALL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Dual-Action drug shows promise in lung cancer fight
Disease control Recruiting nowThis study tests a new drug called ivonescimab, which helps the immune system attack cancer and blocks blood vessels that feed tumors. About 60 adults with advanced small cell lung cancer who haven't had treatment will get ivonescimab plus standard chemo. The goal is to find the …
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CANCER
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 16, 2026 04:51 UTC
-
New hope for tough lung cancer: tarlatamab trial targets patients with poor health
Disease control Recruiting nowThis study tests a drug called tarlatamab in 48 people with advanced small cell lung cancer who have already tried one standard treatment. Participants receive tarlatamab through an IV until their cancer worsens or side effects become too severe. The main goal is to see how many …
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CANCER
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 16, 2026 04:48 UTC